Capital World Investors Biogen Inc. Transaction History

Capital World Investors

$597 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $7.61 Million - $9.16 Million	34,200 New	34,200 $8.85 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $93.7 Million - $122 Million	-330,992 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $80.4 Million - $94.2 Million	330,992 New	330,992 $92.6 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $75.1 Million - $113 Million	-317,974 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $79.6 Million - $91.9 Million	300,474 Added 1716.99%	317,974 $90.2 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $181 Million - $240 Million	-700,908 Reduced 97.56%	17,500 $4.68 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $298 Million - $378 Million	-1,109,838 Reduced 60.71%	718,408 $227 Million
Q4 2019 Feb 18, 2020	SELL	$220.06 - $304.07 $313 Million - $433 Million	-1,423,225 Reduced 43.77%	1,828,246 $542 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $179 Million - $201 Million	-823,456 Reduced 20.21%	3,251,471 $757 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $181 Million - $200 Million	-826,933 Reduced 16.87%	4,074,927 $953 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $192 Million - $300 Million	886,293 Added 22.07%	4,901,860 $1.16 Billion
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $429 Million - $544 Million	1,541,859 Added 62.33%	4,015,567 $1.21 Billion
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $606 Million - $792 Million	2,063,598 Added 503.18%	2,473,708 $874 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $51.6 Million - $61.5 Million	200,483 Added 95.64%	410,110 $119 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $28.7 Million - $40.6 Million	110,227 Added 110.89%	209,627 $57.4 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $30.6 Million - $34.3 Million	99,400	99,400 $31.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account